WASHINGTON, July 8 -- Sen. Susan M. Collins, R-Maine, issued the following statement on July 6, 2023: * * * Today, U.S. Senator Susan Collins (R-ME), the chairman and founder of the Senate Alzheimer's Task Force, expressed support for the U.S. Food and Drug Administration's (FDA) decision to grant full approval of the Alzheimer's drug, Leqembi: "FDA's approval of Leqembi is a new milestone in the treatment of Alzheimer's disease and is welcome news for millions of Americans and their families more PR